Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Mathieu BASTARD"'
Autor:
Sooyeon Kho, Kwonjune J. Seung, Helena Huerga, Mathieu Bastard, Palwasha Y. Khan, Carole D. Mitnick, Michael L. Rich, Shirajul Islam, Dali Zhizhilashvili, Lusine Yeghiazaryan, Elena Nikolaevna Nikolenko, Khin Zarli, Sana Adnan, Naseem Salahuddin, Saman Ahmed, Zully Haydee Ruíz Vargas, Amsalu Bekele, Aiman Shaimerdenova, Meseret Tamirat, Alain Gelin, Stalz Charles Vilbrun, Catherine Hewison, Uzma Khan, Molly Franke
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-7 (2024)
Abstract Sputum culture reversion after conversion is an indicator of tuberculosis (TB) treatment failure. We analyze data from the endTB multi-country prospective observational cohort (NCT03259269) to estimate the frequency (primary endpoint) among
Externí odkaz:
https://doaj.org/article/3ff129144518404289f68dc07e3488e7
Autor:
Lise Grout, Yves Katuala Givo, Trish Newport, Tom Adoum Mahamat, Priscillah Gitahi, Jean Jacques Mandagot, Michel Quere, Sophie Wodon, Iza Ciglenecki, Mathieu Bastard, Francis Baelongandi, Louis Tshulo, Herman Jakisa Uluba, Esther Sterk, Etienne Gignoux
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background Angumu health zone in Ituri, Democratic Republic of Congo, is a highly malaria-endemic area with an overburdened health system and hosting internally displaced persons (IDP). The World Health Organization recommends mass drug admi
Externí odkaz:
https://doaj.org/article/3536199a0a2b461aa87efaf13c0d558d
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Tuberculosis (TB) is a major cause of ill health worldwide. Until the coronavirus (COVID-19) pandemic, TB was the leading cause of death from a single infectious agent. COVID-19 has caused enormous health, social and economic upheavals since 2020, im
Externí odkaz:
https://doaj.org/article/7ac62367eace4d89aa3a548e97c5c21a
Autor:
Ana Klein, Mathieu Bastard, Hamayoun Hemat, Saschveen Singh, Bruno Muniz, Guyguy Manangama, Amber Alayyan, Abdul Hakim Tamanna, Bashir Barakzaie, Nargis Popal, Mohammad Azeem Zmarial Kakar, Elisabeth Poulet, Flavio Finger
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 8, p e0001687 (2023)
Though many studies on COVID have been published to date, data on COVID-19 epidemiology, symptoms, risk factors and severity in low- and middle-income countries (LMICS), such as Afghanistan are sparse. To describe clinical characteristics, severity,
Externí odkaz:
https://doaj.org/article/4ed86eaaa5704865be48bfb2b98092e8
Autor:
Carly A Rodriguez, Sara Lodi, C Robert Horsburgh, Carole D Mitnick, Mathieu Bastard, Helena Huerga, Uzma Khan, Michael Rich, Kwonjune J Seung, Sidney Atwood, Md Manzur-Ul-Alam, Nara Melikyan, Stephanie Mpinda, Zaw Myint, Yugandran Naidoo, Ofelya Petrosyan, Naseem Salahuddin, Samreen Sarfaraz, Stalz Charles Vilbrun, Kalkidan Yae, Jay Achar, Saman Ahmed, Elena Algozhina, Jude Beauchamp, Sara de Guadelupe Perea Moreno, Munara Gulanbaeva, Marika Gergedava, Cut Yulia Indah Sari, Catherine Hewison, Palwasha Khan, Molly F Franke
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 4, p e0000818 (2023)
Clarity about the role of delamanid in longer regimens for multidrug-resistant TB is needed after discordant Phase IIb and Phase III randomized controlled trial results. The Phase IIb trial found that the addition of delamanid to a background regimen
Externí odkaz:
https://doaj.org/article/c6b18224da1245a6b31dc56b95bc2ad2
Autor:
Carly A Rodriguez, Sara Lodi, C Robert Horsburgh, Mathieu Bastard, Cathy Hewison, Helena Huerga, Munira Khan, Palwasha Y Khan, Uzma Khan, Lawrence Oyewusi, Shrivani Padayachee, Carole D Mitnick, Molly F Franke
Publikováno v:
PLoS ONE, Vol 17, Iss 11, p e0276457 (2022)
BackgroundConversion of sputum culture from positive to negative for M. tuberculosis is a key indicator of treatment response. An initial positive culture is a pre-requisite to observe conversion. Consequently, patients with a missing or negative ini
Externí odkaz:
https://doaj.org/article/546b67b03a514604b1e503e3ca58be18
Autor:
Tobias Broger, Lisa Koeppel, Helena Huerga, Poppy Miller, Ankur Gupta-Wright, François-Xavier Blanc, Aliasgar Esmail, Byron W P Reeve, Marco Floridia, Andrew D Kerkhoff, Fausto Ciccacci, Margaret P Kasaro, Swe Swe Thit, Mathieu Bastard, Gabriella Ferlazzo, Christina Yoon, Daniël J Van Hoving, Bianca Sossen, Juan Ignacio García, Matthew J Cummings, Rachel M Wake, Josh Hanson, Adithya Cattamanchi, Graeme Meintjes, Gary Maartens, Robin Wood, Grant Theron, Keertan Dheda, Ioana Diana Olaru, Claudia M Denkinger, Suzette Oelofse, Didier Laureillard, Mauro Andreotti, Obvious Nchimunya Chilyabanyama, Benjamin Welu, Lucas Molfino, Sekai Chenai Mathabire Rücker, Elisabeth Szumilin, Loide Cossa, Johanna Meléndez, Linda Mbuthini, Max O'Donnell, Joseph N Jarvis, Gcobisa Ndlangalavu, Katherine Fielding
Publikováno v:
The Lancet Global Health. 11:e903-e916
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c1eb32cd4f1f5e8b9816858c1c9e366
https://doi.org/10.1016/s2214-109x(23)00135-3
https://doi.org/10.1016/s2214-109x(23)00135-3
Autor:
Uzma Khan, Helena Huerga, Aamir J. Khan, Carole D. Mitnick, Catherine Hewison, Francis Varaine, Mathieu Bastard, Michael Rich, Molly F. Franke, Sidney Atwood, Palwasha Y. Khan, Kwonjune J. Seung
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaquiline and delamanid was a critical development in the MDR-TB
Externí odkaz:
https://doaj.org/article/5c779cd6d31044b88b3e17992de23a3a
Autor:
Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, Nyasha Bakare, Mathieu Bastard, Eric Caumes, Mathilde Fréchet-Jachym, Jérôme Robert, Nicolas Veziris, Naira Khachatryan, Tinatin Kotrikadze, Armen Hayrapetyan, Zaza Avaliani, Holger J. Schünemann, Christian Lienhardt
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 5, Pp 936-943 (2019)
Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia,
Externí odkaz:
https://doaj.org/article/aca51c7af9fb4ceb917fdc54305dfd56
Autor:
Helena Huerga, Gabriella Ferlazzo, Stephen Wanjala, Mathieu Bastard, Paolo Bevilacqua, Elisa Ardizzoni, Joseph Sitienei, Maryline Bonnet
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Empirical treatment of tuberculosis (TB) may be necessary in patients with negative or no Xpert MTB/RIF results. In a context with access to Xpert, we assessed mortality in the 6 months after the initial TB consultation among HIV-
Externí odkaz:
https://doaj.org/article/73a6b3ff8a2b400fa377044f471f57eb